192 related articles for article (PubMed ID: 35421352)
21. Microbial Arsenal of Antiviral Defenses - Part I.
Isaev AB; Musharova OS; Severinov KV
Biochemistry (Mosc); 2021 Mar; 86(3):319-337. PubMed ID: 33838632
[TBL] [Abstract][Full Text] [Related]
22. Evolutionary Dynamics between Phages and Bacteria as a Possible Approach for Designing Effective Phage Therapies against Antibiotic-Resistant Bacteria.
Hasan M; Ahn J
Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884169
[TBL] [Abstract][Full Text] [Related]
23. A broadly distributed predicted helicase/nuclease confers phage resistance via abortive infection.
Sather LM; Zamani M; Muhammed Z; Kearsley JVS; Fisher GT; Jones KM; Finan TM
Cell Host Microbe; 2023 Mar; 31(3):343-355.e5. PubMed ID: 36893733
[TBL] [Abstract][Full Text] [Related]
24. Knowing Our Enemy in the Antimicrobial Resistance Era: Dissecting the Molecular Basis of Bacterial Defense Systems.
Martínez M; Rizzuto I; Molina R
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732145
[TBL] [Abstract][Full Text] [Related]
25. Systematic discovery of antiphage defense systems in the microbial pangenome.
Doron S; Melamed S; Ofir G; Leavitt A; Lopatina A; Keren M; Amitai G; Sorek R
Science; 2018 Mar; 359(6379):. PubMed ID: 29371424
[TBL] [Abstract][Full Text] [Related]
26. Resistance is not futile: bacterial 'innate' and CRISPR-Cas 'adaptive' immune systems.
Fineran PC
Microbiology (Reading); 2019 Aug; 165(8):834-841. PubMed ID: 30958259
[TBL] [Abstract][Full Text] [Related]
27. SspABCD-SspFGH Constitutes a New Type of DNA Phosphorothioate-Based Bacterial Defense System.
Wang S; Wan M; Huang R; Zhang Y; Xie Y; Wei Y; Ahmad M; Wu D; Hong Y; Deng Z; Chen S; Li Z; Wang L
mBio; 2021 Apr; 12(2):. PubMed ID: 33906925
[TBL] [Abstract][Full Text] [Related]
28. In defense of phage: viral suppressors of CRISPR-mediated adaptive immunity in bacteria.
Wiedenheft B
RNA Biol; 2013 May; 10(5):886-90. PubMed ID: 23392292
[TBL] [Abstract][Full Text] [Related]
29. Aminoglycoside Antibiotics Inhibit Phage Infection by Blocking an Early Step of the Infection Cycle.
Kever L; Hardy A; Luthe T; Hünnefeld M; Gätgens C; Milke L; Wiechert J; Wittmann J; Moraru C; Marienhagen J; Frunzke J
mBio; 2022 Jun; 13(3):e0078322. PubMed ID: 35506667
[TBL] [Abstract][Full Text] [Related]
30. A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.
Malone LM; Warring SL; Jackson SA; Warnecke C; Gardner PP; Gumy LF; Fineran PC
Nat Microbiol; 2020 Jan; 5(1):48-55. PubMed ID: 31819217
[TBL] [Abstract][Full Text] [Related]
31. A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity.
Seed KD; Lazinski DW; Calderwood SB; Camilli A
Nature; 2013 Feb; 494(7438):489-91. PubMed ID: 23446421
[TBL] [Abstract][Full Text] [Related]
32. Discovery of phage determinants that confer sensitivity to bacterial immune systems.
Stokar-Avihail A; Fedorenko T; Hör J; Garb J; Leavitt A; Millman A; Shulman G; Wojtania N; Melamed S; Amitai G; Sorek R
Cell; 2023 Apr; 186(9):1863-1876.e16. PubMed ID: 37030292
[TBL] [Abstract][Full Text] [Related]
33. Disabling a Type I-E CRISPR-Cas Nuclease with a Bacteriophage-Encoded Anti-CRISPR Protein.
Pawluk A; Shah M; Mejdani M; Calmettes C; Moraes TF; Davidson AR; Maxwell KL
mBio; 2017 Dec; 8(6):. PubMed ID: 29233895
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the CRISPR-Cas system in bacteriophages active on epidemic strains of Vibrio cholerae in Bangladesh.
Naser IB; Hoque MM; Nahid MA; Tareq TM; Rocky MK; Faruque SM
Sci Rep; 2017 Nov; 7(1):14880. PubMed ID: 29093571
[TBL] [Abstract][Full Text] [Related]
35. Microbial Arsenal of Antiviral Defenses. Part II.
Isaev AB; Musharova OS; Severinov KV
Biochemistry (Mosc); 2021 Apr; 86(4):449-470. PubMed ID: 33941066
[TBL] [Abstract][Full Text] [Related]
36. Prokaryotic homologs of Argonaute proteins are predicted to function as key components of a novel system of defense against mobile genetic elements.
Makarova KS; Wolf YI; van der Oost J; Koonin EV
Biol Direct; 2009 Aug; 4():29. PubMed ID: 19706170
[TBL] [Abstract][Full Text] [Related]
37. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
Hwang S; Maxwell KL
CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
[TBL] [Abstract][Full Text] [Related]
38. Degradation of Phage Transcripts by CRISPR-Associated RNases Enables Type III CRISPR-Cas Immunity.
Jiang W; Samai P; Marraffini LA
Cell; 2016 Feb; 164(4):710-21. PubMed ID: 26853474
[TBL] [Abstract][Full Text] [Related]
39. Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species.
Pawluk A; Staals RH; Taylor C; Watson BN; Saha S; Fineran PC; Maxwell KL; Davidson AR
Nat Microbiol; 2016 Jun; 1(8):16085. PubMed ID: 27573108
[TBL] [Abstract][Full Text] [Related]
40. [CRISPR-Cas system and coevolution of bacteria and phages].
Li TM; Du B
Yi Chuan; 2011 Mar; 33(3):213-8. PubMed ID: 21402528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
